HFEA/LinkedIn
Jun 18, 2026, 13:25
Zoe’s Experience Living With The Antiphospholipid Syndrome – HFEA
Human Fertilisation and Embryology Authority (HFEA) shared a post on LinkedIn:
”Antiphospholipid syndrome (APS) is a rare autoimmune disorder affecting around 1 in 2000 people in the UK. It increases the risk of blood clots in various parts of the body. In our latest blog, Zoe, a member of our Patient Engagement Forum, shares her experience living with the condition and the impact that it has had on her fertility journey.
Read Zoe’s blog.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 3, 2026, 14:19Asmaa Khaled: The Success of IVF is Not Determined By the Number of Eggs Retrieved Alone…
-
Aug 3, 2026, 14:03Clare Mansfield: Sometimes the Path to Parenthood Changes, but the Dream Doesn’t Have To
-
Aug 3, 2026, 13:45Undiga Emuekpere: Basic Fertility Health Awareness Could Change Outcomes
-
Aug 3, 2026, 13:31Priyadatt Patel: A Quiet Inefficiency in How We Approach Infertility Deserves More Attention
-
Aug 3, 2026, 13:21Purabi Gunjal: Most Women Start Thinking about Fertility Too Late…
-
Aug 3, 2026, 13:10Juhee Jain: Empowering Women with the Right Information to Make Informed Decisions
-
Aug 3, 2026, 12:57Ashley Evans: Sometimes, the Thing that Got Me Through Fertility Treatment Wasn’t Positivity…
-
Aug 3, 2026, 12:42Devyanshi Dixit: Why Do the Best Healthcare Professionals Never Stop Learning?
-
Aug 3, 2026, 12:30Bringing Together the Brightest Minds in Reproductive Medicine for 3 Days at MEFS 2026
